Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

DEAE-Dextran × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Thoracic 2 Genitourinary 2 Head & Neck 1 Breast 1

Conditions

Head and Neck Carcinoma 1

Interventions

Cisplatin 627 Radiotherapy 338 pembrolizumab 327 Cetuximab 283 Docetaxel 224 Radiotherapy, Intensity-Modulated 220 Fluorouracil 199 Carboplatin 197 Paclitaxel 160 Nivolumab 144 Gemcitabine 124 Magnetic Resonance Spectroscopy 98 Radiation 90 Drug Therapy 86 Capecitabine 75 toripalimab 72 Surveys and Questionnaires 72 Surgical Procedures, Operative 72 Biopsy 62 durvalumab 61 Chemoradiotherapy 51 Blood Specimen Collection 50 Cyclophosphamide 48 Specimen Handling 46 Radiosurgery 46 Erlotinib Hydrochloride 46 camrelizumab 45 Standard of Care 43 130-nm albumin-bound paclitaxel 43 Platinum 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06572423 2026-02-05

PULS-Pal

Jonsson Comprehensive Cancer Center

Phase NA Recruiting

Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡